Skip to content

C W Callaway

3 papers in the library · 105 citations · publishing 1991-1992

Papers

Sort Most recent Most cited

Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist.

Journal of Pharmacology and Experimental Therapeutics October 1, 1992 C W Callaway, Mark A. Geyer

Previous studies indicate that 3,4-methylenedioxymethamphetamine (MDMA) produces locomotor hyperactivity in rats by increasing the presynaptic release of serotonin (5-HT). Interactions between MDMA and 5-HT receptor antagonists suggest that the activating effects of MDMA are mediated via 5-HT1-like receptors. In order to assess the contribution of particular 5-HT receptor subtypes to the...

DOI: 10.1016/s0022-3565(25)10342-x (opens in new tab) Brain Animals Rats, sprague-dawley N-methyl-3,4-methylenedioxyamphetamine +6

Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat.

European Journal of Pharmacology April 7, 1992 C W Callaway, Mark A. Geyer 35 citations

This study examined the behavioral effects in rats of intracerebral administration of S(+)-3,4-methylenedioxymethamphetamine (S-MDMA) using an automated holeboard and open-field apparatus. Administration of S-MDMA into the nucleus accumbens septi produced locomotor hyperactivity. Although the stimulant effects of S-MDMA administered systemically are antagonized by fluoxetine pretreatment, the...

Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.

Psychopharmacology 1991 C W Callaway, M P Johnson, L H Gold et al. 70 citations

Derivatives of amphetamine are potent releasers of both dopamine (DA) and serotonin (5-HT), but the relative contributions of DA and 5-HT release to the behavioral effects of these drugs have not been established. Previously, S-(+)3,4-methylenedioxymethamphetamine (S-(+)MDMA) was found to produce locomotor hyperactivity in rats which was dependent on 5-HT release. The present study found that...